EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

When ‘Dirty’ Drugs Become Useful: Peptide-Guided Exposure Engineering for the Repurposing of Cancer Drugs

Serena Marchiò iD

International Journal of Molecular Sciences · 05.03.2026 · 27 (5) · 2400

DOI: 10.3390/ijms27052400 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.03.2026. Verfasst von Serena Marchiò. Beteiligte Einrichtung: Department of Oncology, University of Turin, 10060 Candiolo, Italy. Hauptthemen laut MEDLINE: Drug Repositioning, Antineoplastic Agents, Peptides, Neoplasms. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondazione AIRC per la Ricerca sul Cancro ETS, Italian Ministry of Health, Italian Ministry of Health, Ricerca Corrente 2026.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug repurposing in oncology is often framed as a drug–target matching exercise, yet many candidates with plausible biological rationales fail in the clinic. In solid tumors, therapeutic outcomes are constrained not only by pharmacological target relevance but also by limited tumor accessibility, heterogeneous intratumoral exposure, loss of context-dependent activity, and dose-limiting systemic toxicity. This perspective argues that repurposing strategies should treat exposure engineering as a design principle alongside molecular selectivity. Peptides that bind cell- or matrix-associated molecules at the tumor site have the potential to implement spatial, temporal, and subcellular control over where and when a drug engages its pharmacological target, thereby enabling confinement of polypharmacology to tumor contexts. Mechanistic modes of peptide-enabled exposure selectivity (homing, anchoring/retention, conditional activation, penetration enhancement, and subcellular biasing), key failure modes, and translational constraints are discussed, together with an exposure-centric screening workflow to prioritize repurposed agents most amenable to peptide-guided rescue. Emphasizing the combination of exposure control and the addressing-element layer clarifies when and how pharmacologically promiscuous drugs may be repurposed safely and effectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drug RepositioningAntineoplastic AgentsPeptidesNeoplasmsHumansAnimalsDrug Delivery Systems

Stichwörter der Autor:innen

cancerdrug deliverydrug repurposingpeptide-functionalized nanoparticlespeptide–drug conjugatestumor targeting

Substanzen

Antineoplastic AgentsPeptides

Autor:innen und Institutionen

  • Department of Oncology, University of Turin, 10060 Candiolo, Italy.
  • Candiolo Cancer Institute, Fondazione del Piemonte per l'Oncologia-Istituto di Ricovero e Cura a Carattere Scientifico (FPO-IRCCS), 10060 Candiolo, Italy.

ORCID-Profile: Serena Marchiò

Förderung

  • Fondazione AIRC per la Ricerca sul Cancro ETS
  • Italian Ministry of Health
  • Italian Ministry of Health, Ricerca Corrente 2026

Zitieren

APA

Marchiò, S. (2026). When ‘Dirty’ Drugs Become Useful: Peptide-Guided Exposure Engineering for the Repurposing of Cancer Drugs. International Journal of Molecular Sciences, 27(5), 2400. https://doi.org/10.3390/ijms27052400

Vancouver

Marchiò S. When ‘Dirty’ Drugs Become Useful: Peptide-Guided Exposure Engineering for the Repurposing of Cancer Drugs. International Journal of Molecular Sciences. 2026;27(5):2400. doi:10.3390/ijms27052400

BibTeX
@article{Marchi2026,
  author = {Marchiò, Serena},
  title = {When ‘Dirty’ Drugs Become Useful: Peptide-Guided Exposure Engineering for the Repurposing of Cancer Drugs},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {5},
  pages = {2400},
  doi = {10.3390/ijms27052400}
}
Kostenlos starten →